Siren »

Ascendis Pharma A S shares owned by Siren

Quarter-by-quarter ownership of Ascendis Pharma A S (ASND) shares owned by Siren from 13F filings

Historical chart of Siren investment in Ascendis Pharma A S

Tip: Access up to 7 years of quarterly data

All positions including Ascendis Pharma A S held by Siren consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Ascendis Pharma A S by Siren

Quarter filed Position value Share count Share price at filing
2024-09-30 $52M 348k 149.31

More positions owned by Siren

Kymera Therapeutics (KYMR)
Beigene Sponsored Adr (BGNE)
Scholar Rock Hldg Corp (SRRK)
Bicara Therapeutics
Argenx SE Sponsored Adr (ARGX)
Crinetics Pharmaceuticals In (CRNX)
Avidity Biosciences Ord (RNA)
Apellis Pharmaceuticals (APLS)
Lexicon Pharmaceuticals Com New (LXRX)
Igm Biosciences (IGMS)
Centessa Pharmaceuticals Sponsored Ads (CNTA)
Ascendis Pharma A/S Sponsored Adr (ASND)
Silence Therapeutics Ads (SLN)
Arrowhead Pharmaceuticals (ARWR)
WAVE Life Sciences SHS (WVE)

View all positions for Siren

Top funds holding Ascendis Pharma A S

RA Capital Management
Westfield Capital Management Company
Artisan Partners Limited Partnership
Henderson Group
T. Rowe Price Associates
Capital Research and Management Company - Division 3
Massachusetts Financial Services
T. Rowe Price Investment Management
Franklin Resources
Invesco
Citadel Advisors
BlackRock
Point72 Asset Management
TimesSquare Capital Management
Brown Advisory Holdings Incorporated

View all funds holding Ascendis Pharma A S